Adverse events, need for hospitalization and systemic immunosuppression in very older patients (over 80 years) treated with anti-PD-1 for metastatic melanomaH. Barailler, Anne Pham‐Ledard, S. Prey et al.|Journal of Geriatric Oncology|2020Cited by 6